We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+6.96%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$4.16B
AUM Growth
+$312M
Cap. Flow
+$49.6M
Cap. Flow %
1.19%
Top 10 Hldgs %
18.39%
Holding
702
New
49
Increased
376
Reduced
176
Closed
46

Top Sells

Rank Stock Value
1
PG icon
Procter & Gamble
PG
+$26.9M
2
YHOO
Yahoo Inc
YHOO
+$20.9M
3
EMC
EMC CORPORATION
EMC
+$19.1M
4
CBRE icon
CBRE Group
CBRE
+$15.9M
5
INTC icon
Intel
INTC
+$15.8M

Sector Composition

Rank Sector Weight
1 Healthcare 25.52%
2 Financials 12.75%
3 Technology 11.83%
4 Communication Services 9.9%
5 Consumer Staples 8.9%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BBY icon
426
Best Buy
BBY
$18B
$1.33M 0.03%
34,749
-121,905
-78% -$4.28M
FL
427
DELISTED
Foot Locker
FL
$1.32M 0.03%
19,520
+6,000
+44% +$374K
TGTX icon
428
TG Therapeutics
TGTX
$8.58B
$1.32M 0.03%
170,000
ALDR
429
DELISTED
Alder Biopharmaceuticals
ALDR
$1.31M 0.03%
+40,000
New +$1.22M
FISV
430
Fiserv Inc
FISV
$27.2B
$1.3M 0.03%
26,186
+1,486
+6% +$77.9K
SRE icon
431
Sempra
SRE
$60.8B
$1.3M 0.03%
24,256
+6,054
+33% +$329K
AERI
432
DELISTED
Aerie Pharmaceuticals
AERI
$1.28M 0.03%
+34,000
New +$750K
TPR icon
433
Tapestry
TPR
$28.8B
$1.27M 0.03%
34,715
+12,813
+59% +$508K
FPRX
434
DELISTED
Five Prime Therapeutics, Inc.
FPRX
$1.26M 0.03%
24,000
-3,000
-11% -$143K
ORLY icon
435
O'Reilly Automotive
ORLY
$72.4B
$1.26M 0.03%
67,395
+18,465
+38% +$346K
ACOR
436
DELISTED
Acorda Therapeutics
ACOR
$1.25M 0.03%
500
AZO icon
437
AutoZone
AZO
$48.3B
$1.25M 0.03%
1,622
+471
+41% +$367K
HUM icon
438
Humana
HUM
$46.7B
$1.24M 0.03%
7,006
+1,816
+35% +$315K
NWL icon
439
Newell Brands
NWL
$2.16B
$1.24M 0.03%
23,468
+5,369
+30% +$278K
SHPG
440
DELISTED
Shire pic
SHPG
$1.24M 0.03%
6,373
-740
-10% -$144K
COR icon
441
Cencora
COR
$60.3B
$1.23M 0.03%
15,234
+1,334
+10% +$114K
L icon
442
Loews
L
$24.3B
$1.23M 0.03%
29,843
+8,093
+37% +$332K
EQIX icon
443
Equinix
EQIX
$107B
$1.22M 0.03%
3,377
+800
+31% +$297K
TCOM icon
444
Trip.com Group
TCOM
$27.5B
$1.21M 0.03%
26,000
+4,000
+18% +$178K
MHK icon
445
Mohawk Industries
MHK
$6.9B
$1.21M 0.03%
6,040
-400
-6% -$82.2K
CPRI icon
446
Capri Holdings
CPRI
$1.77B
$1.2M 0.03%
25,649
+8,110
+46% +$404K
COL
447
DELISTED
Rockwell Collins
COL
$1.19M 0.03%
14,155
+5,029
+55% +$424K
ISRG icon
448
Intuitive Surgical
ISRG
$121B
$1.19M 0.03%
14,760
+3,933
+36% +$301K
WY icon
449
Weyerhaeuser
WY
$17.3B
$1.18M 0.03%
36,892
-21,277
-37% -$673K
AZN icon
450
AstraZeneca
AZN
$263B
$1.17M 0.03%
17,840
-2,160
-11% -$141K

Similar funds

Candriam SCA's Q3 2016 Portfolio in Review

As of Q3 2016, Candriam SCA held 702 positions worth $4.16B, up 8.1% from $3.85B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Candriam SCA's Q3 2016 filing shows 49 new, 376 increased, 176 reduced and 46 closed positions. Its largest new stake was Zions Bancorporation: 362,062 shares worth $11.2M. The largest sale was Procter & Gamble, an estimated $26.9M.

By sector, the portfolio is most concentrated in Healthcare at 26% of assets, up from 25% a quarter earlier, followed by Financials and Technology.

  • Candriam SCA's largest Q3 2016 buy was Zions Bancorporation: 362,062 shares worth $11.2M.
  • Candriam SCA added most to Canadian National Railway in Q3 2016, an estimated $30.2M increase.
  • Candriam SCA's biggest Q3 2016 reduction was Procter & Gamble, cutting an estimated $26.9M.
  • Candriam SCA fully exited EMC CORPORATION in Q3 2016, selling an estimated $19.1M.
  • Candriam SCA's ten largest holdings make up 18% of its $4.16B portfolio in Q3 2016.
  • Candriam SCA opened 49 new positions and closed 46 in Q3 2016.
  • Candriam SCA's portfolio value rose 8.1% quarter-over-quarter to $4.16B.

Based on Candriam SCA's 13F filing for Q3 2016, filed 15 Nov 2016.